Take your partners, please--signal diversification by the erbB family of receptor tyrosine kinases - PubMed (original) (raw)

Review

Take your partners, please--signal diversification by the erbB family of receptor tyrosine kinases

R J Daly. Growth Factors. 1999.

No abstract available

PubMed Disclaimer

Similar articles

• Localization and modulation of ErbB receptor tyrosine kinases.
  Carraway KL 3rd, Sweeney C. Carraway KL 3rd, et al. Curr Opin Cell Biol. 2001 Apr;13(2):125-30. doi: 10.1016/s0955-0674(00)00188-5. Curr Opin Cell Biol. 2001. PMID: 11248544 Review.
• Activation of Ras and other signaling pathways by receptor tyrosine kinases.
  Schlessinger J, Bar-Sagi D. Schlessinger J, et al. Cold Spring Harb Symp Quant Biol. 1994;59:173-9. doi: 10.1101/sqb.1994.059.01.021. Cold Spring Harb Symp Quant Biol. 1994. PMID: 7587067 Review. No abstract available.
• Cell signaling by receptor tyrosine kinases.
  Schlessinger J. Schlessinger J. Cell. 2000 Oct 13;103(2):211-25. doi: 10.1016/s0092-8674(00)00114-8. Cell. 2000. PMID: 11057895 Review. No abstract available.
• Application of Immunofluorescence Staining to Study ErbB Family of Receptor Tyrosine Kinases.
  Nami B, Wang Z. Nami B, et al. Methods Mol Biol. 2017;1652:109-116. doi: 10.1007/978-1-4939-7219-7_7. Methods Mol Biol. 2017. PMID: 28791637
• ERBB receptors in cancer: signaling from the inside.
  Arteaga CL. Arteaga CL. Breast Cancer Res. 2011 Mar 16;13(2):304. doi: 10.1186/bcr2829. Breast Cancer Res. 2011. PMID: 21457523 Free PMC article.

Cited by

• Molecular Correlates of In Vitro Responses to Dacomitinib and Afatinib in Bladder Cancer.
  Tamura S, Wang Y, Veeneman B, Hovelson D, Bankhead A 3rd, Broses LJ, Lorenzatti Hiles G, Liebert M, Rubin JR, Day KC, Hussain M, Neamati N, Tomlins S, Palmbos PL, Grivas P, Day ML. Tamura S, et al. Bladder Cancer. 2018 Jan 20;4(1):77-90. doi: 10.3233/BLC-170144. Bladder Cancer. 2018. PMID: 29430509 Free PMC article.
• Inhibition of the HER2 pathway by n-3 polyunsaturated fatty acids prevents breast cancer in fat-1 transgenic mice.
  Zou Z, Bellenger S, Massey KA, Nicolaou A, Geissler A, Bidu C, Bonnotte B, Pierre AS, Minville-Walz M, Rialland M, Seubert J, Kang JX, Lagrost L, Narce M, Bellenger J. Zou Z, et al. J Lipid Res. 2013 Dec;54(12):3453-63. doi: 10.1194/jlr.M042754. Epub 2013 Sep 19. J Lipid Res. 2013. PMID: 24052576 Free PMC article.
• Urothelial carcinomas: a focus on human epidermal receptors signaling.
  Grivas PD, Day M, Hussain M. Grivas PD, et al. Am J Transl Res. 2011 Aug 15;3(4):362-73. Epub 2011 Jul 25. Am J Transl Res. 2011. PMID: 21904656 Free PMC article.
• Combined inhibition of PLC{gamma}-1 and c-Src abrogates epidermal growth factor receptor-mediated head and neck squamous cell carcinoma invasion.
  Nozawa H, Howell G, Suzuki S, Zhang Q, Qi Y, Klein-Seetharaman J, Wells A, Grandis JR, Thomas SM. Nozawa H, et al. Clin Cancer Res. 2008 Jul 1;14(13):4336-44. doi: 10.1158/1078-0432.CCR-07-4857. Clin Cancer Res. 2008. PMID: 18594017 Free PMC article.
• Emerging therapies in gastrointestinal cancers.
  Nautiyal J, Rishi AK, Majumdar AP. Nautiyal J, et al. World J Gastroenterol. 2006 Dec 14;12(46):7440-50. doi: 10.3748/wjg.v12.i46.7440. World J Gastroenterol. 2006. PMID: 17167831 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Taylor & Francis

• Other Literature Sources

  • The Lens - Patent Citations

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal